The pharmacokinetics of porcine glucose-dependent insulinotropic polypeptide (GIP) in man

Eur J Clin Invest. 1982 Dec;12(6):457-61. doi: 10.1111/j.1365-2362.1982.tb02224.x.

Abstract

The pharmacokinetics of porcine glucose-dependent insulinotropic polypeptide were investigated in six healthy volunteers. At the maximum infusion dose (0 . 5 pmol kg-1 min-1) a plateau concentration of 115 +/- 5 . 0 pmol/l plasma was obtained. On discontinuation of the infusion, the half-time of disappearance was calculated to be 20 . 3 +/- 1 . 2 min. The metabolic clearance rate was 2 . 6 +/- 0 . 1 ml kg-1 min-1 and the apparent space of distribution was 75 . 8 +/- 5 . 7 ml kg-1. Blood glucose, pancreatic and gastrointestinal hormones remained at basal concentrations throughout. No side effects were noted by any of the subjects studied.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Animals
  • Blood Glucose / metabolism
  • Female
  • Gastric Inhibitory Polypeptide / administration & dosage
  • Gastric Inhibitory Polypeptide / blood*
  • Gastrointestinal Hormones / blood*
  • Half-Life
  • Humans
  • Infusions, Parenteral
  • Insulin / blood
  • Kinetics
  • Male
  • Metabolic Clearance Rate
  • Pancreatic Hormones / blood
  • Swine

Substances

  • Blood Glucose
  • Gastrointestinal Hormones
  • Insulin
  • Pancreatic Hormones
  • Gastric Inhibitory Polypeptide